These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 16355333)

  • 1. Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter?
    Peterson LR
    Clin Infect Dis; 2006 Jan; 42(2):224-33. PubMed ID: 16355333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes?
    Rothermel CD
    Clin Infect Dis; 2004 May; 38 Suppl 4():S346-9. PubMed ID: 15127368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
    Feldman C
    J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptococcus pneumoniae: does antimicrobial resistance matter?
    Lynch JP; Zhanel GG
    Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic options for pneumococcal pneumonia in Turkey.
    Oncu S; Erdem H; Pahsa A
    Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Penicillin-resistant pneumococci and the empirical use of penicillins in the treatment of community-acquired acute pneumonia].
    Sánchez C; Armengol R; Mir I; Lite J; Garau J
    Enferm Infecc Microbiol Clin; 1992; 10(6):334-9. PubMed ID: 1391015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens.
    Song JH; Jung SI; Ki HK; Shin MH; Ko KS; Son JS; Chang HH; Kim SW; Lee H; Kim YS; Oh WS; Peck KR; Chongthaleong A; Lalitha MK; Perera J; Yee TT; Jamal F; Kamarulzaman A; Carlos CC; So T;
    Clin Infect Dis; 2004 Jun; 38(11):1570-8. PubMed ID: 15156445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current use of penicillin in community-acquired pneumococcal pneumonias].
    Gaztelurrutia L; Zalacaín R; Rubio G; Hernández JL; Urra E; Hernández M; Garea C; Barrón J
    Enferm Infecc Microbiol Clin; 1994 Jan; 12(1):17-20. PubMed ID: 8155749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?
    Falcó V; Almirante B; Jordano Q; Calonge L; del Valle O; Pigrau C; Planes AM; Gavaldà J; Pahissa A
    J Antimicrob Chemother; 2004 Aug; 54(2):481-8. PubMed ID: 15215226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of pneumococcal pneumonia.
    Pallares R
    Semin Respir Infect; 1999 Sep; 14(3):276-84. PubMed ID: 10501315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does penicillin remain the drug of choice for pneumococcal pneumonia in view of emerging in vitro resistance?
    Chiou CC
    Clin Infect Dis; 2006 Jan; 42(2):234-7. PubMed ID: 16355334
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of penicillin-resistant pneumococcus with penicillin: a case report.
    Spencer J; Gonzalez L; Miller RP; Myers ML
    J Fam Pract; 1997 May; 44(5):499-503. PubMed ID: 9152269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand.
    Reechaipichitkul W; Assawasanti K; Chaimanee P
    Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):320-6. PubMed ID: 17124993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome.
    Yu VL; Chiou CC; Feldman C; Ortqvist A; Rello J; Morris AJ; Baddour LM; Luna CM; Snydman DR; Ip M; Ko WC; Chedid MB; Andremont A; Klugman KP;
    Clin Infect Dis; 2003 Jul; 37(2):230-7. PubMed ID: 12856216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia.
    Metlay JP; Hofmann J; Cetron MS; Fine MJ; Farley MM; Whitney C; Breiman RF
    Clin Infect Dis; 2000 Mar; 30(3):520-8. PubMed ID: 10722438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe pneumococcal pneumonia: new strategies for management.
    Chiou CC; Yu VL
    Curr Opin Crit Care; 2006 Oct; 12(5):470-6. PubMed ID: 16943728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract infections in adults.
    Korsgaard J; Møller JK; Kilian M
    Int J Infect Dis; 2005 Sep; 9(5):274-9. PubMed ID: 16095941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumonia due to resistant Streptococcus pneumoniae.
    Täuber MG
    Schweiz Med Wochenschr; 2000 Dec; 130(49):1873-9. PubMed ID: 11153392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escalation of antimicrobial resistance among Streptococcus pneumoniae: implications for therapy.
    Lynch JP; Zhanel GG
    Semin Respir Crit Care Med; 2005 Dec; 26(6):575-616. PubMed ID: 16388429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
    Jones RN; Sader HS; Stilwell MG; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.